The Non-PVC IV bags market was valued at $880.21 million in 2021 and is estimated to reach $1,684.50 million by 2031, exhibiting a CAGR of 6.7% from 2022 to 2031.
Non-PVC IV bags are intravenous bags made up of non-polyvinyl chloride film. Non-PVC IV bags help reduce the risks associated with conventional IV bags, such as transportation issues and drug interactions with packaging and disposable containers. There is a rise in demand for non-PVC IV bags, which causes shift in the company’s focus on manufacturing PVC-free bags due to the benefits provided by PVC-free IV bags. This is expected to propel the market growth. These bags are quite popular in oncology therapy due to the associated benefits such as less pollution, safety, compatibility, lightweight, convenience to use, and low risk of contamination.
The growth of the global non-PVC IV bags market is majorly driven by increase in demand for non-PVC IV bags, owing to increase in number of cardiac surgical procedures increases the demand for non-PVC IV bags for transporting the fluids. For instance, according to the World Health Organization (WHO), nearly 90% of Chronic Obstructive Pulmonary Disease (COPD) deaths under 70 years of aged occur in low- and middle-income countries (LMIC). Thus, increase in cardiac surgical procedures has led to increase in the demand for non-PVC IV bags, as these bags are providing intravenous fluids to cardiac patients and receiving treatment for acute exacerbations.
In addition, increase in cases of Hospital Acquired Infections (HAI), due to lack of sanitation is the factor responsible for the market growth. For instance, Centers for Disease Control (CDC), estimated that around 1.7 million hospital acquired infections and 99,000 associated deaths each year occurred in the U.S. Thus, rise in cases of Hospital Acquired Infections (HAI) require intravenous antibiotics for weeks thereby increasing the demand for non-PVC IV bags.
Furthermore, increase in awareness regarding non-PVC IV bags in developed countries such as the U.S. and rise in improved designs of non-PVC IV bags further fuel the market growth. However, high cost of non-PVC IV bags and inadequate training to hospital staff about disposal of non-PVC IV bags hinders the market growth. Conversely, increase in demand for non-PVC IV bags and rise in advanced features in non-PVC IV bags are anticipated to provide lucrative opportunities to the market players.
The non-PVC IV bags market is segmented into product type, material type, end user, and region. By product type, the market is categorized into single chamber and multi chamber. By material type, the market is segregated into polypropylene IV bags, polyethylene IV bag, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global non-PVC IV bags market are B. Braun SE, BAUSCH Advanced Technology Group, Fagron Sterile Services US, Fresenius SE & Co. KGaA, ICU Medical, Inc., JW Holdings, KRATON CORPORATION, MEDI PHARMA PLAN Co.,Ltd. Sippex IV bags, and Technoflex.
Non-PVC IV bags are intravenous bags made up of non-polyvinyl chloride film. Non-PVC IV bags help reduce the risks associated with conventional IV bags, such as transportation issues and drug interactions with packaging and disposable containers. There is a rise in demand for non-PVC IV bags, which causes shift in the company’s focus on manufacturing PVC-free bags due to the benefits provided by PVC-free IV bags. This is expected to propel the market growth. These bags are quite popular in oncology therapy due to the associated benefits such as less pollution, safety, compatibility, lightweight, convenience to use, and low risk of contamination.
The growth of the global non-PVC IV bags market is majorly driven by increase in demand for non-PVC IV bags, owing to increase in number of cardiac surgical procedures increases the demand for non-PVC IV bags for transporting the fluids. For instance, according to the World Health Organization (WHO), nearly 90% of Chronic Obstructive Pulmonary Disease (COPD) deaths under 70 years of aged occur in low- and middle-income countries (LMIC). Thus, increase in cardiac surgical procedures has led to increase in the demand for non-PVC IV bags, as these bags are providing intravenous fluids to cardiac patients and receiving treatment for acute exacerbations.
In addition, increase in cases of Hospital Acquired Infections (HAI), due to lack of sanitation is the factor responsible for the market growth. For instance, Centers for Disease Control (CDC), estimated that around 1.7 million hospital acquired infections and 99,000 associated deaths each year occurred in the U.S. Thus, rise in cases of Hospital Acquired Infections (HAI) require intravenous antibiotics for weeks thereby increasing the demand for non-PVC IV bags.
Furthermore, increase in awareness regarding non-PVC IV bags in developed countries such as the U.S. and rise in improved designs of non-PVC IV bags further fuel the market growth. However, high cost of non-PVC IV bags and inadequate training to hospital staff about disposal of non-PVC IV bags hinders the market growth. Conversely, increase in demand for non-PVC IV bags and rise in advanced features in non-PVC IV bags are anticipated to provide lucrative opportunities to the market players.
The non-PVC IV bags market is segmented into product type, material type, end user, and region. By product type, the market is categorized into single chamber and multi chamber. By material type, the market is segregated into polypropylene IV bags, polyethylene IV bag, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global non-PVC IV bags market are B. Braun SE, BAUSCH Advanced Technology Group, Fagron Sterile Services US, Fresenius SE & Co. KGaA, ICU Medical, Inc., JW Holdings, KRATON CORPORATION, MEDI PHARMA PLAN Co.,Ltd. Sippex IV bags, and Technoflex.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the non-pvc iv bags market analysis from 2021 to 2031 to identify the prevailing non-pvc iv bags market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the non-pvc iv bags market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global non-pvc iv bags market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
- Single Chamber
- Multi Chamber
By Material Type
- Polypropylene IV Bag
- Polyethylene IV Bag
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- ICU Medical, Inc.
- JW Holdings
- B. Braun SE
- KRATON CORPORATION
- Sippex IV bags
- Fresenius SE and Co. KGaA
- BAUSCH Advanced Technology Group
- Fagron Sterile Services US
- Technoflex
- MEDI PHARMA PLAN Co.,Ltd.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: NON-PVC IV BAGS MARKET, BY PRODUCT TYPE
CHAPTER 5: NON-PVC IV BAGS MARKET, BY MATERIAL TYPE
CHAPTER 6: NON-PVC IV BAGS MARKET, BY END USER
CHAPTER 7: NON-PVC IV BAGS MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report titled, “Non-PVC IV Bags Market" the non-pvc iv bags market was valued at $880.21 million in 2021, and is estimated to reach $1,684.5 million by 2031, growing at a CAGR of 6.7% from 2022 to 2031.Non-PVC IV bags are considered to be safe and easy to handle and transport. These bags are made from polypropylene (PP) and ethylene-vinyl acetate (EVA) without the use of any plasticizers. These bags need to be used in operating rooms. The bags are connected to an IV catheter via a tubing system which contains IV fluid and patient receive the fluid through the IV catheter. These bags efficiently administer the fluids include fluids, electrolytes, and drugs to patients. These bags are quite popular in oncology therapy due to the associated benefits such as less pollution, safety, compatibility, lightweight, convenience to use, and low risk of contamination.
Key factors driving the growth of the non-PVC IV bags market include rise in focus on healthcare sector and adoption of non-PVC IV bags due to its advantages such as ecofriendly in nature and convenient to handle & transport. For instance, MULTILAYER PP BAGS manufactured by Sippex IV bags company offers benefits such as high clearness of the material, greater safety in the administration of the solution and used for antibiotics, biotechnology, oncology department. Thus, such benefits provided by these bags drive the market growth.
In addition, rise in oncology procedures requires non-PVC IV bags for administration of solutions and medications for patients. Thus, there is an increase in demand for these bags in the oncology department as these bags play an important role in operation theaters which supports the market growth. Furthermore, increase in elderly population and rise in incidence of chronic disorders have increased the demand for non-PVC IV bags to deliver the medications and fluids which drive the market growth.
Moreover, rise in burden of chronic diseases such as cancer, cardiovascular diseases, respiratory diseases and others is expected to increase the demand for non-PVC IV bags and drive the market growth. For instance, World Health Organization (WHO), stated that chronic disease prevalence increased by 57% in 2020. Thus, rise in adoption of non-PVC IV bags, rise in oncology procedures, and increase in burden of chronic diseases supports the market growth.
The market also offers growth opportunities to the key players in the market. Rise in demand for non-PVC IV bags due to rise in prevalence of chronic diseases in developing countries is expected to provide lucrative opportunities for the non-PVC bags market. In addition, rise in health care expenditure significantly impacts growth of various sectors in the healthcare industry. Thus, increase in healthcare spending, surge in demand for medical devices and rise in usage of non-PVC IV bags are expected to provide remunerative opportunities for expansion of the global non-PVC bags market during the forecast period.
The non-PVC IV bags market is segmented into product type, material type, end user, and region. On the basis of product type, the market is categorized into single chamber and multi chamber. On the basis of material type, it is categorized into polypropylene IV bags, polyethylene IV bag, and others. On the basis of end user, it is classified into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players profiled in the study include B. Braun SE, BAUSCH Advanced Technology Group, Fagron Sterile Services US, Fresenius SE & Co. KGaA, ICU Medical, Inc., JW Holdings, KRATON CORPORATION, MEDI PHARMA PLAN Co.,Ltd. Sippex IV bags, and Technoflex. The players in the market have been actively engaged in the adoption various strategies such as product launch, acquisition, and agreement to remain competitive and gain advantage over the competitors in the market. For instance, in August 2022, ICU Medical Inc. announced that it has entered into a long-term agreement with Grifols to provide customers non-PVC/non-DEHP IV containers for 0.9% Sodium Chloride Injection, USP in U.S. ICU Medical's non-PVC/non-DEHP product line now include container sizes from 50 mL to 1000 mL due to this new agreement.
Key Market Insights
- By product type, the single chamber segment was the highest revenue contributor to the market and is estimated to reach $1,198.5 million by 2031, with a CAGR of 6.3%. However, the multi chamber segment is estimated to be the fastest-growing segment with a CAGR of 7.6% during the forecast period. By material type, the polypropylene IV bag segment dominated the global market in 2021 and is expected to be the fastest-growing segment with a CAGR of 7.6% during the forecast period.
- Based on end user, the hospitals segment was the highest revenue contributor to the market in 2021.
- Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 8.4% during the forecast period
Companies Mentioned
- ICU Medical, Inc.
- JW Holdings
- B. Braun SE
- KRATON CORPORATION
- Sippex IV bags
- Fresenius SE and Co. KGaA
- BAUSCH Advanced Technology Group
- Fagron Sterile Services US
- Technoflex
- MEDI PHARMA PLAN Co.,Ltd.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Related Reports
From
Non-PVC IV Bags Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
- Report
- 138 Pages
- Global
From
From
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
